Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Ebola Hemorrhagic Fever

glucose, (beta-d)-isomer has been researched along with Ebola Hemorrhagic Fever in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cooper, K; Fisher, C; Hagen, KR; Jahrling, PB; Johnson, RF; Keshwara, R; Kurup, D; Papaneri, A; Perry, DL; Schnell, MJ; Ter Meulen, J; Wang, JT; Wirblich, C1

Other Studies

1 other study(ies) available for glucose, (beta-d)-isomer and Ebola Hemorrhagic Fever

ArticleYear
An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models.
    The Journal of infectious diseases, 2016, 10-15, Volume: 214, Issue:suppl 3

    Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Ebola Vaccines; Ebolavirus; Emulsions; Female; Glucosides; Hemorrhagic Fever, Ebola; Lipid A; Macaca fascicularis; Macaca mulatta; Male; Rabies; Rabies Vaccines; Rabies virus; Toll-Like Receptor 4; Vaccines, Inactivated; Vaccines, Synthetic

2016